EBIT at other companies
Other financials
Where this comes from
Calculated from Perspective Therapeutics’s reported figures.
The official record: Perspective Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Perspective Therapeutics's ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Perspective Therapeutics's EBIT?
- Perspective Therapeutics (CATX) reported EBIT of -$28.28M in Q1 2026.
- How has Perspective Therapeutics's EBIT changed year-over-year?
- Perspective Therapeutics's EBIT decreased by 29.5% year-over-year, from -$21.83M to -$28.28M.
- What is the long-term trend for Perspective Therapeutics's EBIT?
- Over 3 years (2022 to 2025), Perspective Therapeutics's EBIT has grown at a 145.3% compound annual growth rate (CAGR), from -$7.69M to -$113.56M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.